1
More than solid – Roxolid® Did you know? Roxolid® is a metal alloy composed of ~ 15 % zirconium and ~ 85 % titanium. The combination of these two metals leads to a material with higher tensile and fatigue strength than comparable Titanium implants 1 . 1. Roxolid® is stronger than Titanium Grade 4 Results -0.60 mm (± 0.69 mm) Titanium Roxolid® The majority of implant sites showed crestal bone loss between 0 and 1.0 mm, or crestal bone gain. 3. Straumann® extends their Roxolid® implant guarantee Roxolid® implants provide a clinically validated safe and reliable alternative to Titanium Grade 4 implants. The improved mechanical properties of Roxolid® extend the indications in implant therapy to more challenging clinical situations and allow promoting a minimal invasive treatment approach. Fatigue strength is the long-term capability of the implant to withstand normal mastificatory forces 85 % 15 % Higher tensile strength Straumann ® R o x o l i d ® L i f e t i m e + G u a r a n t e e O u r q u a l i t y . Y o u r a s s u r a n c e . Straumann® has so much confidence in the quality and durability of every Roxolid® implant, that we offer an industry-leading guarantee. The Roxolid® Lifetime Plus Guarantee not only covers the implant, but also part of the treatment cost in case of an implant fracture. Higher fatigue strength Straumann® Roxolid® [MPa] 1000 [MPa] 825 Straumann® Titanium Grade 4 Ultimate tensile strength is the maximum force that a material withstands without breaking Indications Double-blind, split-mouth design. Roxolid® and Titanium Grade 4 implant randomly allocated to one side. Study design 2 2. Success and survival of Roxolid® implants is maintained over time Study centers Switzerland United Kingdom Germany Italy Average age Products Study duration Patient number 5 Years 47 72 ± 8 Years 3.3 mm Titanium SLActive®, Bone Level Control 24 male 23 female There is no statistical difference between the crestal bone level changes for Roxolid® compared to titanium implants five years after implant placement. Ø 3.3 mm 25 20 15 10 5 Higher fatigue strength (%) Roxolid® SLActive® in comparison to Titanium SLActive® BL NC BLT NC TL RN S TL RN SP TL RN TE [MPa] 550 Standard Titanium Grade 4 Bone level change Implant survival Test 3.3 mm Roxolid® SLActive®, Bone Level -0.61 mm (± 0.83 mm) + 11 % + 11 % + 21 % + 17 % Titanium SLActive® 97.8 % Roxolid® SLActive® 98.9 % 0 1 Medvedev A, Molotnikov A, Lapovok R, Zeller R, Berner S., Habersetzer P et al. (2015). Microstructure and mechanical properties of Ti-Grade4 versus Ti-15Zr used as materials for dental implants (submitted). 2 Müller F, Al-Nawas B, Storelli S, Quirynen M, Hicklin S, Castro-Laza J et al. (2015). Small-diameter titanium grade IV and titanium- zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlled trial. BMC Oral Health. 2015 Oct 12;15(1):123. (1):123.1186/s12903-015-0107-6. + 21 % Slight bone loss Bone gain Bone loss > 2.0 mm 73 % 18 % 61 % 25% 14 % 9 % Titanium SLActive® Roxolid® SLActive®

More than solid – Roxolid® - Straumann · Straumann® has so much confidence in the quality and . ... Control. 24. male 23 . female There ... Slight bone loss Bone gain. Bone loss

Embed Size (px)

Citation preview

More than solid – Roxolid®

Did you know?

Roxolid® is a metal alloy composed of ~ 15 % zirconium and ~ 85 % titanium. The combination of these two metals leads to a material with

higher tensile and fatigue strength than comparable Titanium implants1.

1. Roxolid® is stronger than Titanium Grade 4

Results

-0.60 mm(± 0.69 mm)

Titanium Roxolid®

The majority of implant sites showed crestal bone loss between 0 and 1.0 mm, or crestal bone gain.

3. Straumann® extends their Roxolid® implant guarantee

Roxolid® implants provide a clinically validated safe and reliable alter native to Titanium Grade 4 implants. The improved mechanical properties of Roxolid® extend the indications in implant therapy to more challenging clinical situations and allow promoting a minimal invasive treatment approach.

Fatigue strength is the long-term capability of the implant to withstand normal mastificatory forces

85 %

15 %

Higher tensile strength

Straumann

®Roxo

lid® Lif

etime+ Guarantee

Our quality. Your assura

nce.

Straumann® has so much confidence in the quality and durability of every Roxolid® implant, that we offer

an industry-leading guarantee. The Roxolid® Lifetime Plus Guarantee not only covers the implant, but also

part of the treatment cost in case of an implant fracture.

Higher fatigue strength

Straumann® Roxolid®

[MPa]

1000[MPa]

825

Straumann® Titanium Grade 4

Ultimate tensile strength is the maximum force that a material withstands without breaking

Indications

Double-blind, split-mouth design. Roxolid® and Titanium Grade 4 implant

randomly allocated to one side.

Study design2

2. Success and survival of Roxolid® implants is maintained over time

Study centers

SwitzerlandUnited Kingdom

GermanyItaly

Average ageProducts Study duration Patient number

5 Years 47 72 ± 8 Years3.3 mm

Titanium SLActive®, Bone Level

Control24

male23

female

There is no statistical difference between the crestal bone level changes for Roxolid® compared to titanium implants five years after implant placement.

Ø 3.3 mm

25

20

15

10

5Hig

her f

atig

ue st

reng

th (%

) Ro

xolid

® SL

Acti

ve®

in c

ompa

rison

to T

itan

ium

SLA

ctiv

BL NC BLT NC TL RN S TL RN SP TL RN TE

[MPa]

550

Standard Titanium Grade 4

Bone level change

Implant survival

Test3.3 mm

Roxolid® SLActive®, Bone Level

-0.61 mm(± 0.83 mm)

+ 11 % + 11 %

+ 21 %

+ 17 %

Titanium SLActive®

97.8 %Roxolid®

SLActive®

98.9 %

0

1 Medvedev A, Molotnikov A, Lapovok R, Zeller R, Berner S., Habersetzer P et al. (2015). Microstructure and mechanical properties of Ti-Grade4 versus Ti-15Zr used as materials for dental implants (submitted). 2 Müller F, Al-Nawas B, Storelli S, Quirynen M, Hicklin S, Castro-Laza J et al. (2015). Small-diameter titanium grade IV and titanium- zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlled trial. BMC Oral Health. 2015 Oct 12;15(1):123. (1):123.1186/s12903-015-0107-6.

+ 21 %

Slight bone loss Bone gain Bone loss > 2.0 mm

73 %

18 %

61 %

25%

14 %9 %

Titanium SLActive® Roxolid® SLActive®

FINAL_Infografik_Roxolid.indd 1 10.12.15 09:19